Associate Director, FP&A

BlueRock Therapeutics, a wholly-owned and independently operated subsidiary of Bayer AG, is a leading engineered cell therapy company pioneering a new generation of cellular medicines. Utilizing our proprietary CELL+GENE™ platform, we direct cellular differentiation and genetically engineer cells to create transformative therapies for patients suffering from neurological and ophthalmological diseases. Founded in 2016, BlueRock is at the forefront of the convergence of cell biology and genetic engineering. Our mission is to harness pluripotent stem cell technology and gene editing to deliver authentic, functional cell therapies that address the root causes of disease and offer hope to millions of patients worldwide. What Are We Doing? Our foundational science enables the generation and directed differentiation of universal pluripotent stem cells into authentic, functional cells for allogeneic cellular therapies. We are passionate about realizing the promise of cell and gene therapy, shaping the future of regenerative medicine, and delivering new therapies to patients with limited or no treatment options. Who is BlueRock? BlueRock Therapeutics, a wholly owned and independently operated subsidiary of Bayer AG, is a leading engineered cell therapy company using its unique cell+gene platform to direct cellular differentiation and genetically engineer cells to create a new generation of cellular medicines that address large patient populations suffering from neurological, cardiovascular, and immunology diseases. The convergence of cell biology and genetic engineering is creating fundamental new ways to impact disease. Founded in 2016 to capitalize on these technological breakthroughs, we are advancing our novel cell+gene platform to develop, manufacture, and deliver an entirely new generation of authentic and engineered cell therapies across three therapeutic areas: neurology, cardiology, and immunology. What Are We Doing? Our foundational science harnesses the ability to create and then direct the differentiation of universal pluripotent stem cells into authentic, functional cells that can be used as allogeneic cellular therapies to treat a broad array of diseases. We can also further engineer these cells, enabling them to produce enzymes, antibodies, and other proteins for additional therapeutic benefit. We are passionate about delivering on the promise of cellular and gene therapy, shaping the future of cellular medicine, and delivering new therapies to millions of patients with treatment options. We are seeking individuals who are collaborative, thrive in a fun and dynamic culture, and are steadfast in the commitment to advance cutting-edge cellular therapies to impact patients’ lives.

Description of Position:

The Associate Director of FP&A will serve as the lead finance partner to our Development & G&A business functions and program teams reporting to the Sr. Director, Financial Planning & Analysis. The incumbent will be a strong contributor to the FP&A function with deep clinical finance expertise while providing strategic and tactical decision support to the Development organization, driving efforts to scale and streamline planning and reporting processes and financial steering to ensure the business meets our financial objectives. This role will be highly visible, developing dynamic and advanced Clinical Trial budget models, managing and executing the strategic business plan, quarterly forecasts, and supporting any ad hoc analysis and other projects.

Responsibilities:

• Strongly work with FP&A to develop Strategic Business Plan Budgets and quarterly forecasts to ensure the Development Team business partners are clear on assumptions and program timelines to meet financial deliverables due to Bayer
• Partner with BlueRock’s Development Leadership Team, G&A Functions and Program leads to oversee and develop the annual operating plan that includes headcount, advanced clinical trial budget models, operating expenses, and capital investments
• Develop advanced clinical trial models critical to short and long range planning, portfolio analysis, and resource decision analysis by partnering with the Development Department & program leads.
• Serve as the lead Finance partner in weekly program team meetings, proactively engaging with cross-functional stakeholders to identify key business drivers, risks, opportunities, and decision points that inform financial strategy, forecasting, resource planning, and investment prioritization.
• Prepare and manage budget/forecast data for input into planning systems the data is accurate and understand key variances to produce key summary reports/presentations
• Develop and manage Corporate financial models to evaluate short-term and long-term financial scenarios.
• Produce management reports on a monthly and quarterly basis that analyze financial performance vs budget and prior forecasts
• Coordinate the preparation of key financial slides for board meetings and executive committee meetings
• Coordinate with accounting department for month end close and provide content around business performance and accrual support to aid in financial reporting.
• Understanding of procurement, procurement controls, and procurement related data structures
• Develop, maintain, and improve processes, tools, and systems to enhance financial tracking and reporting, including driving the implementation of new FP&A tool - shifting away from excel based planning

Minimum Requirements:

• Bachelor’s degree, preferably in Accounting, Finance, Business Administration or similar field, is required
• 8 or more years of experience in Accounting, Consulting, Financial Planning & Analysis (FP&A) field is preferred
• Life Sciences (biotechnology, pharmaceuticals, medical device) industry experience is preferred
• Strong Excel Modeling skills, including skills such as Vlookup, Index/Match, Pivots, What if scenarios, etc.
• Strong understanding of clinical trials, corporate finance, including the interaction of income statement, cash flow statement, and balance sheet is preferred
• Knowledge of Oracle Planning Tools and Coupa (procurement) applications preferred
• Strong interpersonal and written and verbal communication skills include the ability to effectively communicate clearly and concisely with all levels
• Demonstrated problem-solving and analytical skills
• Thrives in fast-paced environments with ability to manage and complete projects with time constraints
• Ability to successfully work independently and within a team environment
• Ability to maintain confidentiality of sensitive information

Equal Opportunity Workplace:

At BlueRock, we welcome and support differences and diversity and we are proud to be an equal opportunity workplace. Please let us know if you require disability-related accommodation or other grounds protected by human rights legislation during the recruitment process so that we can work with you to meet your needs.

The estimated compensation range for this position is $ 160,000.00 - $ 170,100.00 per year.

Equal Opportunity Workplace:

At BlueRock, we welcome and support differences and diversity and we are proud to be an equal opportunity workplace. Please let us know if you require disability-related accommodation or other grounds protected by human rights legislation during the recruitment process so that we can work with you to meet your needs.

We may use artificial intelligence (AI) tools to support parts of the hiring process, such as reviewing applications, analyzing resumes, or assessing responses. These tools assist our recruitment team but do not replace human judgment. Final hiring decisions are ultimately made by humans. If you would like more information about how your data is processed, please contact us.

BlueRock Therapeutics is a clinical stage cell therapy company focused on creating cellular medicines to treat devastating diseases. We are harnessing the power of cell therapy to create a pipeline of new medicines for people suffering from neurological and ophthalmic diseases. Two of our novel investigational cell therapies, one for the treatment of Parkinson’s disease and one for the treatment of primary photoreceptor diseases, are clinical stage programs. BlueRock was founded in 2016 as a joint venture of Versant Ventures and Leaps by Bayer, the impact investing arm of Bayer AG that invests in paradigm-shifting breakthrough innovation. In late 2019, BlueRock became a wholly owned, independently operated subsidiary of Bayer AG. Our culture is defined by the courage to persist regardless of the challenge, the urgency to transform medicine and deliver hope, integrity guided by mission, and community-mindedness with the understanding that we are all part of something bigger than ourselves.